Participated · Series A · Nov 2025

Athian builds a software platform that streamlines data entry, uploads, measurement, and verification at scale to drive greenhouse-gas (GHG) emission reductions for livestock producers and the food brands that source from them. By improving the accuracy and efficiency of Scope 3 emissions tracking, the company enables food companies to fund farm-level sustainability measures while mitigating enterprise risk. Athian’s tools aim to bolster both the financial and environmental resilience of farms within global supply chains. Led by CEO Paul Myer, the firm positions itself as a key enabler for brands seeking to meet ambitious climate targets. The platform specifically supports funding mechanisms that reward producers for lowering emissions. While detailed operating metrics such as revenue or user count were not disclosed, the company’s immediate focus is expanding its technological capabilities and market reach with newly secured capital.

Participated · Series A · Jan 2021

Resilient Biotics has built a drug-discovery platform that combines bioinformatics and machine learning to identify and validate microbiome-based biotherapeutics for preventing and treating respiratory infections in animals. Its flagship product, RBX001, is an intranasal, non-antibiotic treatment aimed at preventing bovine respiratory disease and has shown very promising results in preclinical studies. The company positions its approach as more targeted and data-driven than traditional direct-fed microbials, aiming to identify which microbial strains matter and understand their mechanisms. Resilient is advancing a pipeline beyond cattle, exploring therapeutics for swine and poultry where respiratory diseases drive high morbidity and mortality. The startup raised $7.1 million in a Series A to continue RBX001 development and expand work on additional microbiome-derived products; a second product is already in development and a third is being planned. Founded in 2017, the company seeks to provide platform-based, antibiotic-alternative solutions for livestock producers and meet growing consumer expectations around food safety and traceability.

Participated · Series A · Mar 2017

Boragen is building a novel synthetic chemistry platform, initially focused on next-generation fungicides designed to reduce fungicide resistance and lower chemical usage per acre while maintaining efficacy. The platform, licensed from Penn State and developed by Stephen J. Benkovic, Ph.D., and C. Tony Liu, Ph.D., targets a novel mode of action to address resistance issues. The company says its lead compound decreases the probability of fungicide resistance and supports more sustainable farming methods. Boragen also believes its chemistry approach could have applications in animal health, crop protection and pharmaceuticals. The company’s scientific team includes researchers from MIT, Penn State, Stanford and The Scripps Research Institute, and its headquarters and labs are located in Research Triangle Park within AgTech Accelerator’s facilities. Boragen was established in 2017.